VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 93 filers reported holding VERVE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $33,228,181 | -3.6% | 2,505,896 | +36.3% | 0.00% | 0.0% |
| Q2 2023 | $34,480,987 | +25.3% | 1,838,986 | -3.6% | 0.00% | +33.3% |
| Q1 2023 | $27,518,000 | +79415.7% | 1,908,364 | +6.7% | 0.00% | -40.0% |
| Q4 2022 | $34,607 | -99.9% | 1,788,462 | -6.8% | 0.01% | -44.4% |
| Q3 2022 | $65,901,000 | +218.4% | 1,918,490 | +41.6% | 0.01% | +200.0% |
| Q2 2022 | $20,699,000 | -18.9% | 1,354,638 | +21.1% | 0.00% | 0.0% |
| Q1 2022 | $25,532,000 | -21.1% | 1,118,834 | +27.5% | 0.00% | -25.0% |
| Q4 2021 | $32,345,000 | -23.5% | 877,298 | -2.5% | 0.00% | -20.0% |
| Q3 2021 | $42,294,000 | -23.7% | 899,865 | -2.2% | 0.01% | -28.6% |
| Q2 2021 | $55,446,000 | – | 920,252 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |